Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 EMD Millipore Receives American Business Awards | Contract Pharma
Breaking News

EMD Millipore Receives American Business Awards

Direct Detect and Muse Products gain national recognition

EMD Millipore, the Life Science division of Merck KGaA, received a Silver Stevie Award for its Muse Cell Analyzer and a Bronze Stevie Award for its Direct Detect Protein Quantitation System from the American Business Awards. The awards are given as a national recognition to new products that have impacted their industries in significant ways.
 
The Muse Cell Analyzer is a miniaturized benchtop flow cytometer that delivers multi-dimensional information on cell populations. It was designed to be more compact, affordable, and simpler to use than traditional systems, and is accessible to researchers of all levels. The Direct Detect system for protein quantitation employs EMD Millipore’s membrane expertise to enable infrared-based measurement of amide bonds in protein chains and enables researchers to improve the speed and accuracy of their quantitation.
 
Warren Hinds, operations manager for EMD Millipore, said, “I was honored to attend the ceremony and accept the awards on behalf of the EMD Millipore R&D, Applications and Operations teams,” said Warren. “We are proud of our accomplishment, and the recognition by the ABA. The awards acknowledge the long history of innovation that has been a hallmark of our success at EMD Millipore.”
 
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters